FDA Adverse Event
Injury
Summary report: N
AMPLATZER SEPTAL OCCLUDER
MDR report key: 2944539
·
Received February 5, 2013
Report
- Report Number
- 2135147-2013-00009
- Event Type
- Injury
- Date Received
- February 5, 2013
- Date of Event
- January 18, 2013
- Report Date
- January 23, 2013
- Manufacturer
- AGA MEDICAL CORPORATION
- Product Code
- MLV
- PMA / PMN Number
- P000039
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
DURING MANUFACTURING, THIS DEVICE UNDERWENT A SERIES OF INSPECTIONS AND TESTS TO CONFIRM PROPER FUNCTION, INCLUDING A TEST SIMULATING LOADING AND DEPLOYMENT. A REVIEW OF MANUFACTURING DOCUMENTATION CONFIRMED THIS DEVICE SUCCESSFULLY COMPLETED THESE TESTS. NO PRODUCT WAS RETURNED. REVIEW OF THE DEVICE HISTORY RECORD CONFIRMED THIS LOT MET MANUFACTURING REQUIREMENTS PRIOR TO SHIPMENT. THE CAUSE FOR THE REPORTED EVENT REMAINS UNKNOWN.
Description of Event or Problem · 1
A 24MM AMPLATZER SEPTAL OCCLUDER (ASO) WAS IMPLANTED. THE NEXT DAY, IT WAS FOUND TO HAVE EMBOLIZED. THE PATIENT WAS ADMITTED FOR SURGERY WHERE THE ASO WAS EXPLANTED AND THE ATRIAL SEPTAL DEFECT WAS SURGICALLY REPAIRED. THE PATIENT IS STABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 48137 | AMPLATZER SEPTAL OCCLUDER | CARDIAC OCCLUSION DEVICE | MLV | AGA MEDICAL CORPORATION | 9-ASD-024 | 1007305484 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |